Testing effectiveness (Phase 2)Ended earlyNCT01528345
What this trial is testing
Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
Who this might be right for
Metastatic Breast Cancer
Novartis Pharmaceuticals 97